Skip to main content
Atrás
Watch Compare

Bio Green Med Solution, Inc.

Calidad de datos: 100%
También listada como BGMSP Nasdaq
BGMS
Nasdaq Manufacturing Chemicals
$1.01
$0.00 (0.00%)
Cap. Mercado: 5.57 M
Precio
$1.01
Cap. Mercado
5.57 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -4.77 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-55.90%
Below sector avg (-53.53%)
ROIC-123.32%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio6.43
Interest Coverage-135.92

Valoración

PE (TTM)
-1.86
Below sector avg (-1.48)
P/B Ratio0.79
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1366 pares)
Métrica Acción Mediana del Sector
P/E -1.9 -1.5
P/B 0.8 1.6
ROE % -55.9 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

No hay estimaciones futuras disponibles

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q32024 -$129.60 -$43.20 +66.7%
Q22024 -$344.40 -$172.80 +49.8%
Q12024 -$1,183.20 -$544.80 +54.0%
Q42023 -$1,524.00 -$1,495.20 +1.9%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -3.00 M
ROE -55.90% ROA -47.74%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -4.77 M
ROIC -123.32% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6.43
Interest Coverage -135.92 Asset Turnover 0.00
Working Capital 5.44 M Tangible Book Value 5.53 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.86 Forward P/E N/A
P/B Ratio 0.79 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -85.57%
Market Cap 5.57 M Enterprise Value 1.74 M
Per Share
EPS (Diluted TTM) -6.45 Revenue / Share 0.00
FCF / Share -0.86 OCF / Share -0.86
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 159.11%
SBC-Adj. FCF -6.65 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 — — — —
Net Income -3.00 M -11.21 M -22.56 M -21.20 M -18.89 M
EPS (Diluted) -6.45 -2.09 -27.24 -1.90 -2.14
Gross Profit — — — — —
Operating Income -8.43 M -12.00 M -25.45 M -27.66 M -22.94 M
EBITDA — — — — —
R&D Expenses 848,000.0 6.66 M 19.16 M 20.27 M 15.48 M
SG&A Expenses — 5.39 M 6.72 M 7.38 M 7.46 M
D&A — — — — —
Interest Expense 62,000.0 — — — —
Income Tax 7,000.0 -782,000.0 -3.00 M -4.72 M -3.85 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.19 M 4.09 M 8.81 M 27.50 M 42.59 M
Total Liabilities 1.34 M 6.27 M 8.20 M 7.50 M 5.32 M
Shareholders' Equity 6.84 M -2.17 M 607,000.0 15.51 M 37.26 M
Total Debt — — — — —
Cash & Equivalents 3.51 M 3.14 M 3.38 M 18.35 M 36.56 M
Current Assets 6.26 M 3.67 M 7.44 M 24.41 M 40.94 M
Current Liabilities 1.33 M 6.27 M 8.16 M 7.39 M 5.29 M